Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Iguratimod suppresses Tfh cell differentiation in primary Sjögren’s syndrome patients through inhibiting Akt/mTOR/STAT3 signaling

Fig. 2

IGU attenuates pSS Tfh cell differentiation in vitro. Flowcytometry analysis of (A) CD4+CXCR5+, (B) CD4+CXCR5+PD-1+, (C) CD4+CXCR5+ICOS+, and (D) CD4+IL-21+ Tfh cells differentiated from pSS naive CD4+ T cells (n = 6) stimulated under Tfh condition for 5 days. Data were presented as mean ± SD. Data were obtained from three independent experiments. *p < 0.05, **p < 0.01 by ANOVA

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us